Page last updated: 2024-08-24

rolofylline and Glomerulonephritis, Minimal Change

rolofylline has been researched along with Glomerulonephritis, Minimal Change in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Erley, CM; Heyne, N; Osswald, H; Risler, T; Yao, K	1

Other Studies

1 other study(ies) available for rolofylline and Glomerulonephritis, Minimal Change

Article	Year
The selective adenosine A1 receptor antagonist KW-3902 prevents radiocontrast media-induced nephropathy in rats with chronic nitric oxide deficiency. European journal of pharmacology, 2001, Feb-23, Volume: 414, Issue:1 Topics: Animals; Blood Pressure; Contrast Media; Diatrizoate; Disease Models, Animal; Diuretics; Diuretics, Osmotic; Enzyme Inhibitors; Glomerular Filtration Rate; Male; Mannitol; Nephrosis, Lipoid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Sodium; Xanthines	2001

Article

Year

The selective adenosine A1 receptor antagonist KW-3902 prevents radiocontrast media-induced nephropathy in rats with chronic nitric oxide deficiency.

European journal of pharmacology, 2001, Feb-23, Volume: 414, Issue:1

Topics: Animals; Blood Pressure; Contrast Media; Diatrizoate; Disease Models, Animal; Diuretics; Diuretics, Osmotic; Enzyme Inhibitors; Glomerular Filtration Rate; Male; Mannitol; Nephrosis, Lipoid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Sodium; Xanthines

2001